Skip to main content
Top
Published in: Molecular Cancer 1/2010

Open Access 01-12-2010 | Research

Arecoline induces HA22T/VGH hepatoma cells to undergo anoikis - involvement of STAT3 and RhoA activation

Authors: Hsiao-Ling Cheng, Shu-Jem Su, Li-Wen Huang, Bau-Shan Hsieh, Yu-Chen Hu, Thu-Ching Hung, Kee-Lung Chang

Published in: Molecular Cancer | Issue 1/2010

Login to get access

Abstract

Background

Our previous study showed that, in basal cell carcinoma cells, arecoline reduces levels of the tumor cell survival factor interleukin-6 (IL-6), increases levels of tumor suppressor factor p53, and elicits cell cycle arrest, followed by apoptosis. In preliminarily studies, we observed that arecoline induces detachment of the human-derived hepatoma cell line HA22T/VGH from the extracellular matrix. In the present study, we explored the fate of the detached HA22T/VGH cells and investigated the underlying mechanism.

Methods

HA22T/VGH cells or primary cultured rat hepatocytes were treated with arecoline, then changes in morphology, viability, apoptosis, and the expression of surface β1-integrin, apoptosis-related proteins, and IL-6 were examined. Furthermore, activation of the signal transducer and activator of transcription 3 (STAT3) pathway and the RhoA/Rock signaling pathway, including p190RhoGAP and Src homology-2 domain-containing phosphatase SHP2, was examined.

Results

A low concentration of arecoline (≤ 100 μg/ml) caused cytoskeletal changes in HA22T/VGH cells, but not hepatocytes, and this was accompanied by decreased β1-integrin expression and followed by apoptosis, indicating that HA22T/VGH cells undergo anoikis after arecoline treatment. IL-6 expression and phosphorylation of STAT3, which provides protection against anoikis, were inhibited and levels of downstream signaling proteins, including Bcl-XL and Bcl-2, were decreased, while Bax expression, mitochondrial cytochrome c release, and caspase-3 activity were increased. In addition, phosphorylation/activation of p190RhoGAP, a RhoA inhibitor, and of its upstream regulator, SHP2, was inhibited by arecoline treatment, while Rho/Rock activation was increased. Addition of the RhoA inhibitor attenuated the effects of arecoline.

Conclusions

This study demonstrated that arecoline induces anoikis of HA22T/VGH cells involving inhibition of STAT3 and increased RhoA/Rock activation and that the STAT3 and RhoA/Rock signaling pathways are connected.
Appendix
Available only for authorised users
Literature
1.
go back to reference Gray JA, Enz A, Spiegel R: Muscarinic agonists for senile dementia: past experience and future trends. Trends Pharmacol Sci. 1989, 85-88. Suppl, Gray JA, Enz A, Spiegel R: Muscarinic agonists for senile dementia: past experience and future trends. Trends Pharmacol Sci. 1989, 85-88. Suppl,
2.
go back to reference Raffaele KC, Berardi A, Asthana S, Morris P, Haxby JV, Soncrant TT: Effects of long-term continuous infusion of the muscarinic cholinergic agonist arecoline on verbal memory in dementia of the Alzheimer type. Psychopharmacol Bull. 1991, 27: 315-319.PubMed Raffaele KC, Berardi A, Asthana S, Morris P, Haxby JV, Soncrant TT: Effects of long-term continuous infusion of the muscarinic cholinergic agonist arecoline on verbal memory in dementia of the Alzheimer type. Psychopharmacol Bull. 1991, 27: 315-319.PubMed
3.
go back to reference Chang MC, Wu HL, Lee JJ, Lee PH, Chang HH, Hahn LJ, Lin BR, Chen YJ, Jeng JH: The induction of prostaglandin E2 production, interleukin-6 production, cell cycle arrest, and cytotoxicity in primary oral keratinocytes and KB cancer cells by areca nut ingredients is differentially regulated by MEK/ERK activation. J Biol Chem. 2004, 279: 50676-50683. 10.1074/jbc.M404465200CrossRefPubMed Chang MC, Wu HL, Lee JJ, Lee PH, Chang HH, Hahn LJ, Lin BR, Chen YJ, Jeng JH: The induction of prostaglandin E2 production, interleukin-6 production, cell cycle arrest, and cytotoxicity in primary oral keratinocytes and KB cancer cells by areca nut ingredients is differentially regulated by MEK/ERK activation. J Biol Chem. 2004, 279: 50676-50683. 10.1074/jbc.M404465200CrossRefPubMed
4.
go back to reference Jeng JH, Wang YJ, Chiang BL, Lee PH, Chan CP, Ho YS, Wang TM, Lee JJ, Hahn LJ, Chang MC: Roles of keratinocyte inflammation in oral cancer: regulating the prostaglandin E2, interleukin-6 and TNF-alpha production of oral epithelial cells by areca nut extract and arecoline. Carcinogenesis. 2003, 24: 1301-1315. 10.1093/carcin/bgg083CrossRefPubMed Jeng JH, Wang YJ, Chiang BL, Lee PH, Chan CP, Ho YS, Wang TM, Lee JJ, Hahn LJ, Chang MC: Roles of keratinocyte inflammation in oral cancer: regulating the prostaglandin E2, interleukin-6 and TNF-alpha production of oral epithelial cells by areca nut extract and arecoline. Carcinogenesis. 2003, 24: 1301-1315. 10.1093/carcin/bgg083CrossRefPubMed
5.
go back to reference Frisch SM, Francis H: Disruption of epithelial cell-matrix interactions induces apoptosis. J Cell Biol. 1994, 124: 619-626. 10.1083/jcb.124.4.619CrossRefPubMed Frisch SM, Francis H: Disruption of epithelial cell-matrix interactions induces apoptosis. J Cell Biol. 1994, 124: 619-626. 10.1083/jcb.124.4.619CrossRefPubMed
6.
go back to reference Frisch SM, Ruoslahti E: Integrins and anoikis. Curr Opin Cell Biol. 1997, 9: 701-706. 10.1016/S0955-0674(97)80124-XCrossRefPubMed Frisch SM, Ruoslahti E: Integrins and anoikis. Curr Opin Cell Biol. 1997, 9: 701-706. 10.1016/S0955-0674(97)80124-XCrossRefPubMed
7.
go back to reference Schlessinger K, Levy DE: Malignant transformation but not normal cell growth depends on signal transducer and activator of transcription 3. Cancer Res. 2005, 65: 5828-5834. 10.1158/0008-5472.CAN-05-0317PubMedCentralCrossRefPubMed Schlessinger K, Levy DE: Malignant transformation but not normal cell growth depends on signal transducer and activator of transcription 3. Cancer Res. 2005, 65: 5828-5834. 10.1158/0008-5472.CAN-05-0317PubMedCentralCrossRefPubMed
9.
go back to reference Arthur WT, Burridge K: RhoA inactivation by p190RhoGAP regulates cell spreading and migration by promoting membrane protrusion and polarity. Mol Biol Cell. 2001, 12: 2711-2720.PubMedCentralCrossRefPubMed Arthur WT, Burridge K: RhoA inactivation by p190RhoGAP regulates cell spreading and migration by promoting membrane protrusion and polarity. Mol Biol Cell. 2001, 12: 2711-2720.PubMedCentralCrossRefPubMed
10.
go back to reference Brouns MR, Matheson SF, Settleman J: p190 RhoGAP is the principal Src substrate in brain and regulates axon outgrowth, guidance and fasciculation. Nat Cell Biol. 2001, 3: 361-367. 10.1038/35070042CrossRefPubMed Brouns MR, Matheson SF, Settleman J: p190 RhoGAP is the principal Src substrate in brain and regulates axon outgrowth, guidance and fasciculation. Nat Cell Biol. 2001, 3: 361-367. 10.1038/35070042CrossRefPubMed
11.
go back to reference Maddox AS, Burridge K: RhoA is required for cortical retraction and rigidity during mitotic cell rounding. J Cell Biol. 2003, 160: 255-265. 10.1083/jcb.200207130PubMedCentralCrossRefPubMed Maddox AS, Burridge K: RhoA is required for cortical retraction and rigidity during mitotic cell rounding. J Cell Biol. 2003, 160: 255-265. 10.1083/jcb.200207130PubMedCentralCrossRefPubMed
12.
go back to reference Neel BG, Gu H, Pao L: The 'Shp'ing news: SH2 domain-containing tyrosine phosphatases in cell signaling. Trends Biochem Sci. 2003, 28: 284-293. 10.1016/S0968-0004(03)00091-4CrossRefPubMed Neel BG, Gu H, Pao L: The 'Shp'ing news: SH2 domain-containing tyrosine phosphatases in cell signaling. Trends Biochem Sci. 2003, 28: 284-293. 10.1016/S0968-0004(03)00091-4CrossRefPubMed
13.
go back to reference Aggarwal BB, Sethi G, Ahn KS, Sandur SK, Pandey MK, Kunnumakkara AB, Sung B, Ichikawa H: Targeting signal-transducer-and-activator-of-transcription-3 for prevention and therapy of cancer: modern target but ancient solution. Ann N Y Acad Sci. 2006, 1091: 151-169. 10.1196/annals.1378.063CrossRefPubMed Aggarwal BB, Sethi G, Ahn KS, Sandur SK, Pandey MK, Kunnumakkara AB, Sung B, Ichikawa H: Targeting signal-transducer-and-activator-of-transcription-3 for prevention and therapy of cancer: modern target but ancient solution. Ann N Y Acad Sci. 2006, 1091: 151-169. 10.1196/annals.1378.063CrossRefPubMed
14.
go back to reference Chen CL, Cen L, Kohout J, Hutzen B, Chan C, Hsieh FC, Loy A, Huang V, Cheng G, Lin J: Signal transducer and activator of transcription 3 activation is associated with bladder cancer cell growth and survival. Mol Cancer. 2008, 7: 78- 10.1186/1476-4598-7-78PubMedCentralCrossRefPubMed Chen CL, Cen L, Kohout J, Hutzen B, Chan C, Hsieh FC, Loy A, Huang V, Cheng G, Lin J: Signal transducer and activator of transcription 3 activation is associated with bladder cancer cell growth and survival. Mol Cancer. 2008, 7: 78- 10.1186/1476-4598-7-78PubMedCentralCrossRefPubMed
15.
go back to reference Berasain C, Castillo J, Perugorria MJ, Latasa MU, Prieto J, Avila MA: Inflammation and liver cancer: new molecular links. Ann N Y Acad Sci. 2009, 1155: 206-221. 10.1111/j.1749-6632.2009.03704.xCrossRefPubMed Berasain C, Castillo J, Perugorria MJ, Latasa MU, Prieto J, Avila MA: Inflammation and liver cancer: new molecular links. Ann N Y Acad Sci. 2009, 1155: 206-221. 10.1111/j.1749-6632.2009.03704.xCrossRefPubMed
16.
go back to reference Gao B: Cytokines, STATs and liver disease. Cell Mol Immunol. 2005, 2: 92-100.PubMed Gao B: Cytokines, STATs and liver disease. Cell Mol Immunol. 2005, 2: 92-100.PubMed
17.
go back to reference Yoshikawa H, Matsubara K, Qian GS, Jackson P, Groopman JD, Manning JE, Harris CC, Herman JG: SOCS-1, a negative regulator of the JAK/STAT pathway, is silenced by methylation in human hepatocellular carcinoma and shows growth-suppression activity. Nat Genet. 2001, 28: 29-35. 10.1038/88225PubMed Yoshikawa H, Matsubara K, Qian GS, Jackson P, Groopman JD, Manning JE, Harris CC, Herman JG: SOCS-1, a negative regulator of the JAK/STAT pathway, is silenced by methylation in human hepatocellular carcinoma and shows growth-suppression activity. Nat Genet. 2001, 28: 29-35. 10.1038/88225PubMed
18.
go back to reference Zhang SQ, Yang W, Kontaridis MI, Bivona TG, Wen G, Araki T, Luo J, Thompson JA, Schraven BL, Philips MR, Neel BG: Shp2 regulates SRC family kinase activity and Ras/Erk activation by controlling Csk recruitment. Mol Cell. 2004, 13: 341-355. 10.1016/S1097-2765(04)00050-4CrossRefPubMed Zhang SQ, Yang W, Kontaridis MI, Bivona TG, Wen G, Araki T, Luo J, Thompson JA, Schraven BL, Philips MR, Neel BG: Shp2 regulates SRC family kinase activity and Ras/Erk activation by controlling Csk recruitment. Mol Cell. 2004, 13: 341-355. 10.1016/S1097-2765(04)00050-4CrossRefPubMed
19.
go back to reference Coleman ML, Sahai EA, Yeo M, Bosch M, Dewar A, Olson MF: Membrane blebbing during apoptosis results from caspase-mediated activation of ROCK I. Nat Cell Biol. 2001, 3: 339-345. 10.1038/35070009CrossRefPubMed Coleman ML, Sahai EA, Yeo M, Bosch M, Dewar A, Olson MF: Membrane blebbing during apoptosis results from caspase-mediated activation of ROCK I. Nat Cell Biol. 2001, 3: 339-345. 10.1038/35070009CrossRefPubMed
20.
go back to reference Taga T, Kishimoto T: Gp130 and the interleukin-6 family of cytokines. Annu Rev Immunol. 1997, 15: 797-819. 10.1146/annurev.immunol.15.1.797CrossRefPubMed Taga T, Kishimoto T: Gp130 and the interleukin-6 family of cytokines. Annu Rev Immunol. 1997, 15: 797-819. 10.1146/annurev.immunol.15.1.797CrossRefPubMed
21.
go back to reference Yang SF, Wang SN, Wu CF, Yeh YT, Chai CY, Chunag SC, Sheen MC, Lee KT: Altered p-STAT3 (tyr705) expression is associated with histological grading and intratumour microvessel density in hepatocellular carcinoma. J Clin Pathol. 2007, 60: 642-648. 10.1136/jcp.2006.036970PubMedCentralCrossRefPubMed Yang SF, Wang SN, Wu CF, Yeh YT, Chai CY, Chunag SC, Sheen MC, Lee KT: Altered p-STAT3 (tyr705) expression is associated with histological grading and intratumour microvessel density in hepatocellular carcinoma. J Clin Pathol. 2007, 60: 642-648. 10.1136/jcp.2006.036970PubMedCentralCrossRefPubMed
22.
go back to reference Grivennikov S, Karin M: Autocrine IL-6 signaling: a key event in tumorigenesis?. Cancer Cell. 2008, 13: 7-9. 10.1016/j.ccr.2007.12.020CrossRefPubMed Grivennikov S, Karin M: Autocrine IL-6 signaling: a key event in tumorigenesis?. Cancer Cell. 2008, 13: 7-9. 10.1016/j.ccr.2007.12.020CrossRefPubMed
23.
go back to reference Chandra JN, Malviya M, Sadashiva CT, Subhash MN, Rangappa KS: Effect of novel arecoline thiazolidinones as muscarinic receptor 1 agonist in Alzheimer's dementia models. Neurochem Int. 2008, 52: 376-383. 10.1016/j.neuint.2007.07.006CrossRefPubMed Chandra JN, Malviya M, Sadashiva CT, Subhash MN, Rangappa KS: Effect of novel arecoline thiazolidinones as muscarinic receptor 1 agonist in Alzheimer's dementia models. Neurochem Int. 2008, 52: 376-383. 10.1016/j.neuint.2007.07.006CrossRefPubMed
24.
go back to reference Xie DP, Chen LB, Liu CY, Zhang CL, Liu KJ, Wang PS: Arecoline excites the colonic smooth muscle motility via M3 receptor in rabbits. Chin J Physiol. 2004, 47: 89-94.PubMed Xie DP, Chen LB, Liu CY, Zhang CL, Liu KJ, Wang PS: Arecoline excites the colonic smooth muscle motility via M3 receptor in rabbits. Chin J Physiol. 2004, 47: 89-94.PubMed
25.
go back to reference Yang YR, Chang KC, Chen CL, Chiu TH: Arecoline excites rat locus coeruleus neurons by activating the M2-muscarinic receptor. Chin J Physiol. 2000, 43: 23-28.PubMed Yang YR, Chang KC, Chen CL, Chiu TH: Arecoline excites rat locus coeruleus neurons by activating the M2-muscarinic receptor. Chin J Physiol. 2000, 43: 23-28.PubMed
26.
go back to reference Vatamaniuk MZ, Horyn OV, Vatamaniuk OK, Doliba NM: Acetylcholine affects rat liver metabolism via type 3 muscarinic receptors in hepatocytes. Life Sci. 2003, 72: 1871-1882. 10.1016/S0024-3205(02)02506-7CrossRefPubMed Vatamaniuk MZ, Horyn OV, Vatamaniuk OK, Doliba NM: Acetylcholine affects rat liver metabolism via type 3 muscarinic receptors in hepatocytes. Life Sci. 2003, 72: 1871-1882. 10.1016/S0024-3205(02)02506-7CrossRefPubMed
27.
go back to reference Burdon D, Patel R, Challiss RA, Blank JL: Growth inhibition by the muscarinic M(3) acetylcholine receptor: evidence for p21(Cip1/Waf1) involvement in G(1) arrest. Biochem J. 2002, 367: 549-559. 10.1042/BJ20020446PubMedCentralCrossRefPubMed Burdon D, Patel R, Challiss RA, Blank JL: Growth inhibition by the muscarinic M(3) acetylcholine receptor: evidence for p21(Cip1/Waf1) involvement in G(1) arrest. Biochem J. 2002, 367: 549-559. 10.1042/BJ20020446PubMedCentralCrossRefPubMed
28.
go back to reference Nicke B, Detjen K, Logsdon CD: Muscarinic cholinergic receptors activate both inhibitory and stimulatory growth mechanisms in NIH3T3 cells. J Biol Chem. 1999, 274: 21701-21706. 10.1074/jbc.274.31.21701CrossRefPubMed Nicke B, Detjen K, Logsdon CD: Muscarinic cholinergic receptors activate both inhibitory and stimulatory growth mechanisms in NIH3T3 cells. J Biol Chem. 1999, 274: 21701-21706. 10.1074/jbc.274.31.21701CrossRefPubMed
29.
go back to reference Strassheim D, May LG, Varker KA, Puhl HL, Phelps SH, Porter RA, Aronstam RS, Noti JD, Williams CL: M3 muscarinic acetylcholine receptors regulate cytoplasmic myosin by a process involving RhoA and requiring conventional protein kinase C isoforms. J Biol Chem. 1999, 274: 18675-18685. 10.1074/jbc.274.26.18675CrossRefPubMed Strassheim D, May LG, Varker KA, Puhl HL, Phelps SH, Porter RA, Aronstam RS, Noti JD, Williams CL: M3 muscarinic acetylcholine receptors regulate cytoplasmic myosin by a process involving RhoA and requiring conventional protein kinase C isoforms. J Biol Chem. 1999, 274: 18675-18685. 10.1074/jbc.274.26.18675CrossRefPubMed
30.
go back to reference Del Re DP, Miyamoto S, Brown JH: RhoA/Rho kinase up-regulate Bax to activate a mitochondrial death pathway and induce cardiomyocyte apoptosis. J Biol Chem. 2007, 282: 8069-8078. 10.1074/jbc.M604298200CrossRefPubMed Del Re DP, Miyamoto S, Brown JH: RhoA/Rho kinase up-regulate Bax to activate a mitochondrial death pathway and induce cardiomyocyte apoptosis. J Biol Chem. 2007, 282: 8069-8078. 10.1074/jbc.M604298200CrossRefPubMed
31.
go back to reference Sebbagh M, Renvoize C, Hamelin J, Riche N, Bertoglio J, Breard J: Caspase-3-mediated cleavage of ROCK I induces MLC phosphorylation and apoptotic membrane blebbing. Nat Cell Biol. 2001, 3: 346-352. 10.1038/35070019CrossRefPubMed Sebbagh M, Renvoize C, Hamelin J, Riche N, Bertoglio J, Breard J: Caspase-3-mediated cleavage of ROCK I induces MLC phosphorylation and apoptotic membrane blebbing. Nat Cell Biol. 2001, 3: 346-352. 10.1038/35070019CrossRefPubMed
32.
go back to reference Van Aelst L, D'Souza-Schorey C: Rho GTPases and signaling networks. Genes Dev. 1997, 11: 2295-2322. 10.1101/gad.11.18.2295CrossRefPubMed Van Aelst L, D'Souza-Schorey C: Rho GTPases and signaling networks. Genes Dev. 1997, 11: 2295-2322. 10.1101/gad.11.18.2295CrossRefPubMed
33.
go back to reference Bromberg JF, Wrzeszczynska MH, Devgan G, Zhao Y, Pestell RG, Albanese C, Darnell JE: Stat3 as an oncogene. Cell. 1999, 98: 295-303. 10.1016/S0092-8674(00)81959-5CrossRefPubMed Bromberg JF, Wrzeszczynska MH, Devgan G, Zhao Y, Pestell RG, Albanese C, Darnell JE: Stat3 as an oncogene. Cell. 1999, 98: 295-303. 10.1016/S0092-8674(00)81959-5CrossRefPubMed
34.
go back to reference Simon AR, Vikis HG, Stewart S, Fanburg BL, Cochran BH, Guan KL: Regulation of STAT3 by direct binding to the Rac1 GTPase. Science. 2000, 290: 144-147. 10.1126/science.290.5489.144CrossRefPubMed Simon AR, Vikis HG, Stewart S, Fanburg BL, Cochran BH, Guan KL: Regulation of STAT3 by direct binding to the Rac1 GTPase. Science. 2000, 290: 144-147. 10.1126/science.290.5489.144CrossRefPubMed
35.
go back to reference Faruqi TR, Gomez D, Bustelo XR, Bar-Sagi D, Reich NC: Rac1 mediates STAT3 activation by autocrine IL-6. Proc Natl Acad Sci USA. 2001, 98: 9014-9019. 10.1073/pnas.161281298PubMedCentralCrossRefPubMed Faruqi TR, Gomez D, Bustelo XR, Bar-Sagi D, Reich NC: Rac1 mediates STAT3 activation by autocrine IL-6. Proc Natl Acad Sci USA. 2001, 98: 9014-9019. 10.1073/pnas.161281298PubMedCentralCrossRefPubMed
36.
go back to reference Aznar S, Valeron PF, del Rincon SV, Perez LF, Perona R, Lacal JC: Simultaneous tyrosine and serine phosphorylation of STAT3 transcription factor is involved in Rho A GTPase oncogenic transformation. Mol Biol Cell. 2001, 12: 3282-3294.PubMedCentralCrossRefPubMed Aznar S, Valeron PF, del Rincon SV, Perez LF, Perona R, Lacal JC: Simultaneous tyrosine and serine phosphorylation of STAT3 transcription factor is involved in Rho A GTPase oncogenic transformation. Mol Biol Cell. 2001, 12: 3282-3294.PubMedCentralCrossRefPubMed
37.
go back to reference Debidda M, Wang L, Zang H, Poli V, Zheng Y: A role of STAT3 in Rho GTPase-regulated cell migration and proliferation. J Biol Chem. 2005, 280: 17275-17285. 10.1074/jbc.M413187200CrossRefPubMed Debidda M, Wang L, Zang H, Poli V, Zheng Y: A role of STAT3 in Rho GTPase-regulated cell migration and proliferation. J Biol Chem. 2005, 280: 17275-17285. 10.1074/jbc.M413187200CrossRefPubMed
38.
go back to reference Puisieux A, Galvin K, Troalen F, Bressac B, Marcais C, Galun E, Ponchel F, Yakicier C, Ji J, Ozturk M: Retinoblastoma and p53 tumor suppressor genes in human hepatoma cell lines. FASEB J. 1993, 7: 1407-1413.PubMed Puisieux A, Galvin K, Troalen F, Bressac B, Marcais C, Galun E, Ponchel F, Yakicier C, Ji J, Ozturk M: Retinoblastoma and p53 tumor suppressor genes in human hepatoma cell lines. FASEB J. 1993, 7: 1407-1413.PubMed
39.
go back to reference Gadea G, de Toledo M, Anguille C, Roux P: Loss of p53 promotes RhoA-ROCK-dependent cell migration and invasion in 3D matrices. J Cell Biol. 2007, 178: 23-30. 10.1083/jcb.200701120PubMedCentralCrossRefPubMed Gadea G, de Toledo M, Anguille C, Roux P: Loss of p53 promotes RhoA-ROCK-dependent cell migration and invasion in 3D matrices. J Cell Biol. 2007, 178: 23-30. 10.1083/jcb.200701120PubMedCentralCrossRefPubMed
40.
go back to reference Xia M, Land H: Tumor suppressor p53 restricts Ras stimulation of RhoA and cancer cell motility. Nat Struct Mol Biol. 2007, 14: 215-223. 10.1038/nsmb1208CrossRefPubMed Xia M, Land H: Tumor suppressor p53 restricts Ras stimulation of RhoA and cancer cell motility. Nat Struct Mol Biol. 2007, 14: 215-223. 10.1038/nsmb1208CrossRefPubMed
41.
go back to reference Karni R, Jove R, Levitzki A: Inhibition of pp60c-Src reduces Bcl-XL expression and reverses the transformed phenotype of cells overexpressing EGF and HER-2 receptors. Oncogene. 1999, 18: 4654-4662. 10.1038/sj.onc.1202835CrossRefPubMed Karni R, Jove R, Levitzki A: Inhibition of pp60c-Src reduces Bcl-XL expression and reverses the transformed phenotype of cells overexpressing EGF and HER-2 receptors. Oncogene. 1999, 18: 4654-4662. 10.1038/sj.onc.1202835CrossRefPubMed
42.
go back to reference Dave BJ, Trivedi AH, Adhvaryu SG: In vitro genotoxic effects of areca nut extract and arecoline. J Cancer Res Clin Oncol. 1992, 118: 283-288. 10.1007/BF01208617CrossRefPubMed Dave BJ, Trivedi AH, Adhvaryu SG: In vitro genotoxic effects of areca nut extract and arecoline. J Cancer Res Clin Oncol. 1992, 118: 283-288. 10.1007/BF01208617CrossRefPubMed
43.
go back to reference Sharan RN, Wary KK: Study of unscheduled DNA synthesis following exposure of human cells to arecoline and extracts of betel nut in vitro. Mutat Res. 1992, 278: 271-276. 10.1016/S0165-1218(10)80007-2CrossRefPubMed Sharan RN, Wary KK: Study of unscheduled DNA synthesis following exposure of human cells to arecoline and extracts of betel nut in vitro. Mutat Res. 1992, 278: 271-276. 10.1016/S0165-1218(10)80007-2CrossRefPubMed
44.
go back to reference Shirname LP, Menon MM, Bhide SV: Mutagenicity of betel quid and its ingredients using mammalian test systems. Carcinogenesis. 1984, 5: 501-503. 10.1093/carcin/5.4.501CrossRefPubMed Shirname LP, Menon MM, Bhide SV: Mutagenicity of betel quid and its ingredients using mammalian test systems. Carcinogenesis. 1984, 5: 501-503. 10.1093/carcin/5.4.501CrossRefPubMed
45.
go back to reference Betel-quid and areca-nut chewing and some areca-nut derived nitrosamines. IARC Monogr Eval Carcinog Risks Hum. 2004, 85: 1-334. Betel-quid and areca-nut chewing and some areca-nut derived nitrosamines. IARC Monogr Eval Carcinog Risks Hum. 2004, 85: 1-334.
46.
go back to reference Jeng JH, Kuo ML, Hahn LJ, Kuo MY: Genotoxic and non-genotoxic effects of betel quid ingredients on oral mucosal fibroblasts in vitro. J Dent Res. 1994, 73: 1043-1049.PubMed Jeng JH, Kuo ML, Hahn LJ, Kuo MY: Genotoxic and non-genotoxic effects of betel quid ingredients on oral mucosal fibroblasts in vitro. J Dent Res. 1994, 73: 1043-1049.PubMed
47.
go back to reference Jeng JH, Tsai CL, Hahn LJ, Yang PJ, Kuo YS, Kuo MY: Arecoline cytotoxicity on human oral mucosal fibroblasts related to cellular thiol and esterase activities. Food Chem Toxicol. 1999, 37: 751-756. 10.1016/S0278-6915(99)00050-2CrossRefPubMed Jeng JH, Tsai CL, Hahn LJ, Yang PJ, Kuo YS, Kuo MY: Arecoline cytotoxicity on human oral mucosal fibroblasts related to cellular thiol and esterase activities. Food Chem Toxicol. 1999, 37: 751-756. 10.1016/S0278-6915(99)00050-2CrossRefPubMed
48.
go back to reference Sundqvist K, Liu Y, Nair J, Bartsch H, Arvidson K, Grafstrom RC: Cytotoxic and genotoxic effects of areca nut-related compounds in cultured human buccal epithelial cells. Cancer Res. 1989, 49: 5294-5298.PubMed Sundqvist K, Liu Y, Nair J, Bartsch H, Arvidson K, Grafstrom RC: Cytotoxic and genotoxic effects of areca nut-related compounds in cultured human buccal epithelial cells. Cancer Res. 1989, 49: 5294-5298.PubMed
49.
go back to reference Lee PH, Chang MC, Chang WH, Wang TM, Wang YJ, Hahn LJ, Ho YS, Lin CY, Jeng JH: Prolonged exposure to arecoline arrested human KB epithelial cell growth: regulatory mechanisms of cell cycle and apoptosis. Toxicology. 2006, 220: 81-89. 10.1016/j.tox.2005.07.026CrossRefPubMed Lee PH, Chang MC, Chang WH, Wang TM, Wang YJ, Hahn LJ, Ho YS, Lin CY, Jeng JH: Prolonged exposure to arecoline arrested human KB epithelial cell growth: regulatory mechanisms of cell cycle and apoptosis. Toxicology. 2006, 220: 81-89. 10.1016/j.tox.2005.07.026CrossRefPubMed
50.
go back to reference Devirgiliis LC, Dini L, Di Pierro A, Leoni S, Spagnuolo S, Stefanini S: An improved non-perfusion method for the isolation and purification of rat foetal and neonatal hepatocytes. Cell Mol Biol. 1981, 27: 687-694. Devirgiliis LC, Dini L, Di Pierro A, Leoni S, Spagnuolo S, Stefanini S: An improved non-perfusion method for the isolation and purification of rat foetal and neonatal hepatocytes. Cell Mol Biol. 1981, 27: 687-694.
51.
go back to reference Belloc F, Belaud-Rotureau MA, Lavignolle V, Bascans E, Braz-Pereira E, Durrieu F, Lacombe F: Flow cytometry detection of caspase 3 activation in preapoptotic leukemic cells. Cytometry. 2000, 40: 151-160. 10.1002/(SICI)1097-0320(20000601)40:2<151::AID-CYTO9>3.0.CO;2-9CrossRefPubMed Belloc F, Belaud-Rotureau MA, Lavignolle V, Bascans E, Braz-Pereira E, Durrieu F, Lacombe F: Flow cytometry detection of caspase 3 activation in preapoptotic leukemic cells. Cytometry. 2000, 40: 151-160. 10.1002/(SICI)1097-0320(20000601)40:2<151::AID-CYTO9>3.0.CO;2-9CrossRefPubMed
52.
go back to reference McGill G, Shimamura A, Bates RC, Savage RE, Fisher DE: Loss of matrix adhesion triggers rapid transformation-selective apoptosis in fibroblasts. J Cell Biol. 1997, 138: 901-911. 10.1083/jcb.138.4.901PubMedCentralCrossRefPubMed McGill G, Shimamura A, Bates RC, Savage RE, Fisher DE: Loss of matrix adhesion triggers rapid transformation-selective apoptosis in fibroblasts. J Cell Biol. 1997, 138: 901-911. 10.1083/jcb.138.4.901PubMedCentralCrossRefPubMed
53.
go back to reference Su SJ, Chow NH, Kung ML, Hung TC, Chang KL: Effects of soy isoflavones on apoptosis induction and G2-M arrest in human hepatoma cells involvement of caspase-3 activation, Bcl-2 and Bcl-XL downregulation, and Cdc2 kinase activity. Nutr Cancer. 2003, 45: 113-123. 10.1207/S15327914NC4501_13CrossRefPubMed Su SJ, Chow NH, Kung ML, Hung TC, Chang KL: Effects of soy isoflavones on apoptosis induction and G2-M arrest in human hepatoma cells involvement of caspase-3 activation, Bcl-2 and Bcl-XL downregulation, and Cdc2 kinase activity. Nutr Cancer. 2003, 45: 113-123. 10.1207/S15327914NC4501_13CrossRefPubMed
54.
go back to reference Livak KJ, Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods. 2001, 25: 402-408. 10.1006/meth.2001.1262CrossRefPubMed Livak KJ, Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods. 2001, 25: 402-408. 10.1006/meth.2001.1262CrossRefPubMed
Metadata
Title
Arecoline induces HA22T/VGH hepatoma cells to undergo anoikis - involvement of STAT3 and RhoA activation
Authors
Hsiao-Ling Cheng
Shu-Jem Su
Li-Wen Huang
Bau-Shan Hsieh
Yu-Chen Hu
Thu-Ching Hung
Kee-Lung Chang
Publication date
01-12-2010
Publisher
BioMed Central
Published in
Molecular Cancer / Issue 1/2010
Electronic ISSN: 1476-4598
DOI
https://doi.org/10.1186/1476-4598-9-126

Other articles of this Issue 1/2010

Molecular Cancer 1/2010 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine